Pub Date : 2023-07-20DOI: 10.12923/2353-8627/2023-0013
Z. Wingralek, Paweł Miś, Hubert Wróblewski, A. Zimna, J. Rog
Introduction: The etiopathogenesis of depression consists of genetic, metabolic, hormonal and psychogenic factors. The pathological process increases the risk and worsens the course of the disorder in chronic low-grade inflammation. Nutrition affects the pro-/anti-inflammatory state, and an anti-inflammatory diet is a proposed form supporting the therapy of inflammatory diseases. The review aimed to determine the importance of an anti-inflammatory diet in supporting the treatment of mood disorders. Materials and methods: The available literature was reviewed by searching the PubMed and Google Scholar databases using the following keywords: nutritional psychiatry, depression, anti-inflammatory diet from the inception to 10th February 2023. We characterized the anti-inflammatory diet, potential mechanisms of action, the epidemiological and intervention studies conducted so far focusing on this topic, as well as barriers to implementation and potentially harmful effects of its implementation. Results: Observational studies show a link between the anti-inflammatory potential of diet and a lower risk of developing mood disorders. The pro-inflammatory profile of the diet is associated with higher severity of depressive symptoms. On the other hand, an anti-inflammatory diet has a beneficial effect on the brain-gut axis and the intestinal microbiota, which are involved in the development of depressive disorders. Conclusions: It is necessary to increase clinical practitioners' and patients' knowledge of the impact of nutrition on mental health. Our team developed recommendations for an anti-inflammatory diet adapted to Polish conditions based on the guidelines. In the case of patients' barriers to implementation, encouraging partial implementation of the recommendations is advised.
{"title":"The importance of anti-inflammatory diet in depression: a literature review and recommendations","authors":"Z. Wingralek, Paweł Miś, Hubert Wróblewski, A. Zimna, J. Rog","doi":"10.12923/2353-8627/2023-0013","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0013","url":null,"abstract":"Introduction: The etiopathogenesis of depression consists of genetic, metabolic, hormonal and psychogenic factors. The pathological process increases the risk and worsens the course of the disorder in chronic low-grade inflammation. Nutrition affects the pro-/anti-inflammatory state, and an anti-inflammatory diet is a proposed form supporting the therapy of inflammatory diseases. The review aimed to determine the importance of an anti-inflammatory diet in supporting the treatment of mood disorders.\u0000\u0000Materials and methods: The available literature was reviewed by searching the PubMed and Google Scholar databases using the following keywords: nutritional psychiatry, depression, anti-inflammatory diet from the inception to 10th February 2023. We characterized the anti-inflammatory diet, potential mechanisms of action, the epidemiological and intervention studies conducted so far focusing on this topic, as well as barriers to implementation and potentially harmful effects of its implementation.\u0000\u0000Results: Observational studies show a link between the anti-inflammatory potential of diet and a lower risk of developing mood disorders. The pro-inflammatory profile of the diet is associated with higher severity of depressive symptoms. On the other hand, an anti-inflammatory diet has a beneficial effect on the brain-gut axis and the intestinal microbiota, which are involved in the development of depressive disorders.\u0000\u0000Conclusions: It is necessary to increase clinical practitioners' and patients' knowledge of the impact of nutrition on mental health. Our team developed recommendations for an anti-inflammatory diet adapted to Polish conditions based on the guidelines. In the case of patients' barriers to implementation, encouraging partial implementation of the recommendations is advised.","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87420565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-30DOI: 10.12923/2353-8627/2023-0012
A. Kulik, Natalia Kajka, A. Banakiewicz, Ewelina Frańczyk
Introduction: The aim of the study was: to assess the severity of Secondary Traumatic Stress (STS), to identify ST's predictors, and to assess the model of relationships between predictors of Secondary Traumatic Stress in psychotherapists working during the pandemic in Poland. Materials and methods: The research group consisted of 153 psychotherapists (130 women, 85%) aged 25-66 (M = 39.39; SD = 9.65). The following tools were used to measure the variables: Coping Inventory for Stressful Situations (CISS), Perceived Stress Scale (PSS-10), Fatigue Severity Scale (FSS), FCV-19S Fear of COVID-19 Scale (FCV-19S), Secondary Traumatic Stress Scale (STSS), Personal Inquiry, Assessment of working conditions during a pandemic. Discussion: It has been shown that 9.8% of psychotherapists working during the pandemic experienced high or very high-intensity of symptoms of Secondary Traumatic Stress. The predictors of STS turned out to be: task-induced stress during the pandemic, emotion-focused stress-coping style, and fear of COVID-19. The proposed model of moderated moderation, which assumes that COVID-19 anxiety that intensifies the emotional style of coping with stress in specialists, has an influence on the relationship between occupational tasks stress during a pandemic and the severity of symptoms of Secondary Traumatic Stress, has not been confirmed. Therefore, there is a need for further exploration of the issue. Conclusions: Research shows an increase in STSD among Polish psychotherapists during covid as well as risk factors intensifying this diagnosis. Keywords: secondary traumatic stress, psychotherapist, anxiety, coping, risk factors
{"title":"Risk factors of Secondary Traumatic Stress in psychotherapists studied during the COVID-19","authors":"A. Kulik, Natalia Kajka, A. Banakiewicz, Ewelina Frańczyk","doi":"10.12923/2353-8627/2023-0012","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0012","url":null,"abstract":"Introduction: The aim of the study was: to assess the severity of Secondary Traumatic Stress (STS), to identify ST's predictors, and to assess the model of relationships between predictors of Secondary Traumatic Stress in psychotherapists working during the pandemic in Poland.\u0000Materials and methods: The research group consisted of 153 psychotherapists (130 women, 85%) aged 25-66 (M = 39.39; SD = 9.65). The following tools were used to measure the variables: Coping Inventory for Stressful Situations (CISS), Perceived Stress Scale (PSS-10), Fatigue Severity Scale (FSS), FCV-19S Fear of COVID-19 Scale (FCV-19S), Secondary Traumatic Stress Scale (STSS), Personal Inquiry, Assessment of working conditions during a pandemic.\u0000Discussion: It has been shown that 9.8% of psychotherapists working during the pandemic experienced high or very high-intensity of symptoms of Secondary Traumatic Stress. The predictors of STS turned out to be: task-induced stress during the pandemic, emotion-focused stress-coping style, and fear of COVID-19. The proposed model of moderated moderation, which assumes that COVID-19 anxiety that intensifies the emotional style of coping with stress in specialists, has an influence on the relationship between occupational tasks stress during a pandemic and the severity of symptoms of Secondary Traumatic Stress, has not been confirmed. Therefore, there is a need for further exploration of the issue.\u0000Conclusions: Research shows an increase in STSD among Polish psychotherapists during covid as well as risk factors intensifying this diagnosis.\u0000\u0000Keywords: secondary traumatic stress, psychotherapist, anxiety, coping, risk factors","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"45 15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88640849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-24DOI: 10.12923/2353-8627/2023-0011
Karolina Ludwikowska-Świeboda
Introduction: The aim of the study was to gain a better understanding of the role of emotion regulation (understood in terms of the intensity of intrusive and deliberate rumination about the death of a spouse) in the etiology of sleep disturbances and somatic symptom disorder in widowed people in late adulthood. Material and methods: The study involved 82 older people (66 women and 16 men) whose spouses had died at least six months before the study. The following measures were used: the Event Related Rumination Inventory (ERRI) to assess the intensity of intrusive and deliberate rumination; the General Health Questionnaire (GHQ-28) (somatic symptoms scale) to assess the intensity of somatic symptom disorder; two items of the arousal subscale from the Event Impact Scale – Revised (IES-R) for evaluating the severity of sleep disorder symptoms; as well as a self-designed demographic data questionnaire. Results: The study showed that the intensity of somatic symptom disorder and sleep disturbances can be explained by intrusive rumination. No relationship was found between deliberate rumination and the severity of these disorders. Additionally, there is a positive relationship between the severity of somatic symptom disorder and the age of the study participants. Conclusions: The present findings can potentially be applied in therapeutic programs for widowed individuals who experience sleep disturbances and somatic symptom disorder as a result of unresolved grief. Keywords: somatic symptom disorder, insomnia, grief, death of a spouse, rumination
{"title":"Rumination about the death of a spouse versus the severity of somatic\u0000symptom disorder and sleep disturbances in widowed individuals in late\u0000adulthood","authors":"Karolina Ludwikowska-Świeboda","doi":"10.12923/2353-8627/2023-0011","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0011","url":null,"abstract":"Introduction: The aim of the study was to gain a better understanding of the role of emotion regulation (understood in terms of the intensity of intrusive and deliberate rumination about the death of a spouse) in the etiology of sleep disturbances and somatic symptom disorder in widowed people in late adulthood. \u0000Material and methods: The study involved 82 older people (66 women and 16 men) whose spouses had died at least six months before the study. The following measures were used: the Event Related Rumination Inventory (ERRI) to assess the intensity of intrusive and deliberate rumination; the General Health Questionnaire (GHQ-28) (somatic symptoms scale) to assess the intensity of somatic symptom disorder; two items of the arousal subscale from the Event Impact Scale – Revised (IES-R) for evaluating the severity of sleep disorder symptoms; as well as a self-designed demographic data questionnaire. \u0000Results: The study showed that the intensity of somatic symptom disorder and sleep disturbances can be explained by intrusive rumination. No relationship was found between deliberate rumination and the severity of these disorders. Additionally, there is a positive relationship between the severity of somatic symptom disorder and the age of the study participants. \u0000Conclusions: The present findings can potentially be applied in therapeutic programs for widowed individuals who experience sleep disturbances and somatic symptom disorder as a result of unresolved grief. \u0000\u0000Keywords: somatic symptom disorder, insomnia, grief, death of a spouse, rumination","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"122 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85198122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-17DOI: 10.12923/2353-8627/2023-0010
Piotr Sikorski, E. Sikorska, Milena Michalska, A. Stec, Kaja Kasarełło, Sylwia Fudalej
Introduction: There are several hypotheses of schizophrenia pathogenesis, including the neurodegenerative theory, which is supported by evidence for the decrease of neuroprotective factors’ serum levels. The proteins, that exert a protective effect on neurons and are researched concerning schizophrenia pathogenesis, include the brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 (NT3), and glial cell line-derived neurotrophic factor (GDNF). This review aims to discuss the role of neuroprotective factors in the development of schizophrenia and their relevance in clinical trials. Material and methods: This review was performed by search of the PubMed, Google Scholar, and Science Direct databases from December 25th, 2022, through January 31st, 2023, using keywords: ‘schizophrenia’, ‘schizophrenia pathogenesis’, ‘neuroprotection’, ‘neurodegeneration’, ‘BDNF’, ‘NGF’, ‘NT3’, and ‘GDNF’. We considered original research papers and systematic reviews published in English or Polish. Additionally, clinical trials, which included the assessment of neuroprotective factors’ levels in schizophrenia as outcome measures, were searched for on clinicaltrials.gov. Results: Lower levels of serum BDNF have been linked to cognitive impairment in schizophrenia. In clinical trials, the assessment of serum BDNF is used as a clinical outcome measure for novel schizophrenia therapies. Schizophrenia has also been associated with reduced peripheral NGF levels. During remission, lower NGF levels correlate with higher severity of negative symptoms. Decreased NT3 and GDNF levels can also be seen, but literature reports are inconsistent. Conclusions: Neuroprotective factors are most likely related to the pathogenesis of schizophrenia. Assessing the serum level of these proteins may prove to be an invaluable element of schizophrenia management. Keywords: schizophrenia, brain-derived neurotrophic factor, nerve growth factor,neurotrophin 3, glial cell line-derived neurotrophic factor
{"title":"Neuroprotective factors in schizophrenia: BDNF, NGF, NT3, GDNF and their connection to the pathogenesis of schizophrenia. A narrative review","authors":"Piotr Sikorski, E. Sikorska, Milena Michalska, A. Stec, Kaja Kasarełło, Sylwia Fudalej","doi":"10.12923/2353-8627/2023-0010","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0010","url":null,"abstract":"Introduction: There are several hypotheses of schizophrenia pathogenesis, including the neurodegenerative theory, which is supported by evidence for the decrease of neuroprotective factors’ serum levels. The proteins, that exert a protective effect on neurons and are researched concerning schizophrenia pathogenesis, include the brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 (NT3), and glial cell line-derived neurotrophic factor (GDNF). This review aims to discuss the role of neuroprotective factors in the development of schizophrenia and their relevance in clinical trials.\u0000Material and methods: This review was performed by search of the PubMed, Google Scholar, and Science Direct databases from December 25th, 2022, through January 31st, 2023, using keywords: ‘schizophrenia’, ‘schizophrenia pathogenesis’, ‘neuroprotection’, ‘neurodegeneration’, ‘BDNF’, ‘NGF’, ‘NT3’, and ‘GDNF’. We considered original research papers and systematic reviews published in English or Polish. Additionally, clinical trials, which included the assessment of neuroprotective factors’ levels in schizophrenia as outcome measures, were searched for on clinicaltrials.gov.\u0000Results: Lower levels of serum BDNF have been linked to cognitive impairment in schizophrenia. In clinical trials, the assessment of serum BDNF is used as a clinical outcome measure for novel schizophrenia therapies. Schizophrenia has also been associated with reduced peripheral NGF levels. During remission, lower NGF levels correlate with higher severity of negative symptoms. Decreased NT3 and GDNF levels can also be seen, but literature reports are inconsistent.\u0000Conclusions: Neuroprotective factors are most likely related to the pathogenesis of schizophrenia. Assessing the serum level of these proteins may prove to be an invaluable element of schizophrenia management.\u0000\u0000Keywords: schizophrenia, brain-derived neurotrophic factor, nerve growth factor,neurotrophin 3, glial cell line-derived neurotrophic factor","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79629915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-21DOI: 10.12923/2353-8627/2023-0008
Aleksander Ryczkowski, E. Rudnicka-Drożak, K. Karakuła
Introduction: Insomnia and obstructive sleep apnea are among the most common sleep-wake disorders. A relatively new category of disorders, studied more thoroughly for only a few years, is the occurrence of symptoms of both obstructive sleep apnea and insomnia in one patient and treating it as a different disease entity. This phenomenon is increasingly referred to as COMISA (Co-morbid insomnia and sleep apnea). The aim of this paper is to: 1) draw attention to this interesting issue, 2) show treatment differences of COMISA from isolated insomnia or obstructive sleep apnea and to help choose better therapy by general practitioners, pulmonologists, and psychiatrists for these patients. Materials and methods: The literature review was based on a search of articles in Medline, PubMed, and Google Scholar from 2012 to 2023 using the keywords: obstructive sleep apnea; insomnia; cognitive behavioral therapy for insomnia; continuous positive airway pressure; COMISA. The analysis included original studies, meta-analyses, and review articles. Discussion: The prevalence of both diseases in patients is importantly higher than in the general population. Many patients with COMISA or OSA alone remain undiagnosed. The most common examination of OSA requires a hospital stay to perform polysomnography or polygraphy (2). A lot of people are not willing to go through with the diagnostic process. Conclusions: It is important that during the standard medical history, doctors take into account the possibility of co-occurrence of these diseases, due to the high risk of not diagnosing them on time. Keywords: Obstructive sleep apnea, Insomnia, Cognitive behavioral therapy for insomnia, Continuous positive airway pressure, COMISA
{"title":"Comorbid Insomnia and Sleep Apnea (COMISA) – a real problem for psychiatrists, pulmonologists, and primary care physicians","authors":"Aleksander Ryczkowski, E. Rudnicka-Drożak, K. Karakuła","doi":"10.12923/2353-8627/2023-0008","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0008","url":null,"abstract":"Introduction: Insomnia and obstructive sleep apnea are among the most common sleep-wake disorders. A relatively new category of disorders, studied more thoroughly for only a few years, is the occurrence of symptoms of both obstructive sleep apnea and insomnia in one patient and treating it as a different disease entity. This phenomenon is increasingly referred to as COMISA (Co-morbid insomnia and sleep apnea).\u0000The aim of this paper is to: 1) draw attention to this interesting issue, 2) show treatment differences of COMISA from isolated insomnia or obstructive sleep apnea and to help choose better therapy by general practitioners, pulmonologists, and psychiatrists for these patients.\u0000Materials and methods: The literature review was based on a search of articles in Medline, PubMed, and Google Scholar from 2012 to 2023 using the keywords: obstructive sleep apnea; insomnia; cognitive behavioral therapy for insomnia; continuous positive airway pressure; COMISA. The analysis included original studies, meta-analyses, and review articles.\u0000Discussion: The prevalence of both diseases in patients is importantly higher than in the general population. Many patients with COMISA or OSA alone remain undiagnosed. The most common examination of OSA requires a hospital stay to perform polysomnography or polygraphy (2). A lot of people are not willing to go through with the diagnostic process.\u0000Conclusions: It is important that during the standard medical history, doctors take into account the possibility of co-occurrence of these diseases, due to the high risk of not diagnosing them on time.\u0000\u0000Keywords: Obstructive sleep apnea, Insomnia, Cognitive behavioral therapy for insomnia, Continuous positive airway pressure, COMISA","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79747504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-16DOI: 10.12923/2353-8627/2023-0007
Anna Maria Gutowska-Ibbs, Agnieszka Permoda-Pachuta, Hanna Karakuła- Juchnowicz
Introduction: Clinical experience, as well as the results of real-world data analysis point to the need for developing a model for the care of patients with drug-resistant depression, which could lead to improved access to effective and safe treatment. Scientific studies carried out to date have unequivocally documented the mode of action of ketamine and identified factors which can influence the efficacy of single infusions of ketamine for depression as well as in cases of affective bipolar disorder. Material and method: Case report including a review of national and international literature and an analysis of the case in the light Polish of EU law. Discussion: The use of ketamine in the treatment of drug-resistant depression raises question regarding its legal qualification, in particular whether such treatment can be characterized as a medical experiment. Conclusions: In the light of international publications, which confirm the validity of the method described above, one might assume that the treatment could be qualified as off-label use of a medicine, but not as a medical experiment as it is understood in the legislation (art. 21 ZawLekU). However, given the nature of this treatment, its qualification as off-label use is not the only one possible and others cannot be immediately ruled out.
{"title":"An analysis of the fulfilment criteria for a medical experiment with regards to the use of intravenous ketamine in the treatment of drugresistant depression","authors":"Anna Maria Gutowska-Ibbs, Agnieszka Permoda-Pachuta, Hanna Karakuła- Juchnowicz","doi":"10.12923/2353-8627/2023-0007","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0007","url":null,"abstract":"Introduction: Clinical experience, as well as the results of real-world data analysis point to the need for developing a model for the care of patients with drug-resistant depression, which could lead to improved access to effective and safe treatment. Scientific studies carried out to date have unequivocally documented the mode of action of ketamine and identified factors which can influence the efficacy of single infusions of ketamine for depression as well as in cases of affective bipolar disorder.\u0000Material and method: Case report including a review of national and international literature and an analysis of the case in the light Polish of EU law.\u0000Discussion: The use of ketamine in the treatment of drug-resistant depression raises question regarding its legal qualification, in particular whether such treatment can be characterized as a medical experiment. \u0000Conclusions: In the light of international publications, which confirm the validity of the method described above, one might assume that the treatment could be qualified as off-label use of a medicine, but not as a medical experiment as it is understood in the legislation (art. 21 ZawLekU). However, given the nature of this treatment, its qualification as off-label use is not the only one possible and others cannot be immediately ruled out.","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73062297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-28DOI: 10.12923/2353-8627/2023-0006
Anna Stefanowicz-Bielska, Magdalena Słomion, M. Rąpała
Introduction: The COVID-19 pandemic has affected life satisfaction of students of medical and health science. The aim of this study was to assess the level of life satisfaction among undergraduate students of nursing, midwifery and emergency medicine during the COVID-19 and to evaluate the impact of adherence to COVID-19 disease prevention measures on their level of life satisfaction. Material and methods: The study was conducted using a self-constructed questionnaire and a standardized psychological questionnaire, the Satisfaction with Life Scale, among students of nursing, midwifery and emergency medicine in the Pomeranian Voivodeship during the COVID-19 pandemic. Results: A total of 37 men and 238 women participated in the study. The mean age of all students was 21.5 (SD±3.83, min-max 19-39). The number of 93% of respondents reported avoiding people who coughed and had a cold, and 85.5% avoided large gatherings. When it comes to 84% of the students, they were vaccinated. As far as 73% of the students are concerned, they estimated that they had a medium level of knowledge about SARS-CoV-2 infection. Most students had a low (39.3%) and medium (32.7%) level of life satisfaction. A total number of 28% of the students reported a high satisfaction with life. There was not evidence of the influence of gender, field of study, year of study and the preventive behaviours on their level of life satisfaction. Conclusions: Most Polish students of nursing, midwifery and emergency medicine had a low and medium level of life satisfaction during the COVID-19 pandemic. Of the possible preventive behaviours, Polish students most often avoided people who coughed and had a cold, and they avoided large gatherings. Not all students registered for vaccination. Keywords: students, life, COVID-19, personal satisfaction
{"title":"Life satisfaction of nursing, midwifery and emergency medicine students\u0000during the COVID-19 pandemic","authors":"Anna Stefanowicz-Bielska, Magdalena Słomion, M. Rąpała","doi":"10.12923/2353-8627/2023-0006","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0006","url":null,"abstract":"Introduction: The COVID-19 pandemic has affected life satisfaction of students of medical and health science. The aim of this study was to assess the level of life satisfaction among undergraduate students of nursing, midwifery and emergency medicine during the COVID-19 and to evaluate the impact of adherence to COVID-19 disease prevention measures on their level of life satisfaction.\u0000Material and methods: The study was conducted using a self-constructed questionnaire and a standardized psychological questionnaire, the Satisfaction with Life Scale, among students of nursing, midwifery and emergency medicine in the Pomeranian Voivodeship during the COVID-19 pandemic.\u0000Results: A total of 37 men and 238 women participated in the study. The mean age of all students was 21.5 (SD±3.83, min-max 19-39). The number of 93% of respondents reported avoiding people who coughed and had a cold, and 85.5% avoided large gatherings. When it comes to 84% of the students, they were vaccinated. As far as 73% of the students are concerned, they estimated that they had a medium level of knowledge about SARS-CoV-2 infection. Most students had a low (39.3%) and medium (32.7%) level of life satisfaction. A total number of 28% of the students reported a high satisfaction with life. There was not evidence of the influence of gender, field of study, year of study and the preventive behaviours on their level of life satisfaction. \u0000Conclusions: Most Polish students of nursing, midwifery and emergency medicine had a low and medium level of life satisfaction during the COVID-19 pandemic. Of the possible preventive behaviours, Polish students most often avoided people who coughed and had a cold, and they avoided large gatherings. Not all students registered for vaccination.\u0000\u0000Keywords: students, life, COVID-19, personal satisfaction","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84605002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-27DOI: 10.12923/2353-8627/2023-0005
Klaudia Kister, Jakub Laskowski, Ewelina Dybała, A. Makarewicz
Background: Telemedicine is one of the most modern and fastest-growing branches of medicine. The most common form is video consultation. We distinguish between synchronous and asynchronous telepsychiatry. This study aims to show the benefits of using telepsychiatry services, the challenges it poses to users, and to evaluate its use against traditional therapy. Materials and methods: A review of literature from 1956-2023 in EMBASE, OpenKnowledge and PubMed databases was conducted. Keywords used were: telepsychiatry, teletherapy, and digital psychiatry. Ninety-eight articles were included. Discussion: Telepsychiatry is an opportunity for regions affected by medical staff shortages. It bypasses cultural barriers, the problem of traveling and reduces the cost of medical point-of-service. Telepsychiatry is an opportunity for patients who do not use psychiatrists due to discrimination in a conservative society. Groups that may find it challenging include the elderly, the blind, and the deaf. Creating a healthy therapeutic alliance through a screen can be impossible, making it difficult to achieve successful therapy. A barrier to developing telepsychiatry is the need for more guidelines for dealing with medical errors. Conclusions: Telemedicine can help in accessing specialized care regardless of location. Telepsychiatry provides a safe and anonymous environment for patients reluctant to receive inpatient therapy. The effectiveness of online therapy is primarily debated. Telepsychiatry should be limited to follow-up consultations and well-known patients - it is a form of complementing the diagnosis and treatment process. The authors point to the need for developing specific guidelines for conducting teletherapy with particular attention to the problem of suicide. Keywords: telepsychiatry, teletherapy, digital psychiatry.
{"title":"Are we ready for Telepsychiatry? Benefits and challenges of digital\u0000psychotherapy","authors":"Klaudia Kister, Jakub Laskowski, Ewelina Dybała, A. Makarewicz","doi":"10.12923/2353-8627/2023-0005","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0005","url":null,"abstract":"Background: Telemedicine is one of the most modern and fastest-growing branches of medicine. The most common form is video consultation. We distinguish between synchronous and asynchronous telepsychiatry. This study aims to show the benefits of using telepsychiatry services, the challenges it poses to users, and to evaluate its use against traditional therapy.\u0000Materials and methods: A review of literature from 1956-2023 in EMBASE, OpenKnowledge and PubMed databases was conducted. Keywords used were: telepsychiatry, teletherapy, and digital psychiatry. Ninety-eight articles were included.\u0000Discussion: Telepsychiatry is an opportunity for regions affected by medical staff shortages. It bypasses cultural barriers, the problem of traveling and reduces the cost of medical point-of-service. Telepsychiatry is an opportunity for patients who do not use psychiatrists due to discrimination in a conservative society. Groups that may find it challenging include the elderly, the blind, and the deaf. Creating a healthy therapeutic alliance through a screen can be impossible, making it difficult to achieve successful therapy. A barrier to developing telepsychiatry is the need for more guidelines for dealing with medical errors.\u0000Conclusions: Telemedicine can help in accessing specialized care regardless of location. Telepsychiatry provides a safe and anonymous environment for patients reluctant to receive inpatient therapy. The effectiveness of online therapy is primarily debated. Telepsychiatry should be limited to follow-up consultations and well-known patients - it is a form of complementing the diagnosis and treatment process. The authors point to the need for developing specific guidelines for conducting teletherapy with particular attention to the problem of suicide.\u0000\u0000Keywords: telepsychiatry, teletherapy, digital psychiatry.","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81627153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-17DOI: 10.12923/2353-8627/2023-0003
Szymon Florek, R. Pudlo, P. Gościniewicz, Ewa Mrukwa-Kominek3
Introduction: There are many reports on the association of various psychiatric disorders with visual impairment. The association of dry eye syndrome with depressive disorders has been particularly well documented. In the context of keratoconus patients group, data on similar relationships are inconclusive. Attempts have also been made to assess the personality of patients suffering from keratoconus, and the first study in this area was produced as early as 1976. Material and methods: For the literature review, full-text medical databases, such as PubMed and Embase, were searched for articles on the association of keratoconus with depressive-anxiety disorder and personality disorder. Articles published within the last 30 years were considered. Results: The personality of patients with keratoconus has been a research issue for many years, but research to date has not clearly defined what personality traits characterise this particular group of patients. Research into the relationship between keratoconus and depressive-anxiety disorders has only recently been conducted, and the results - although inconclusive - suggest a co-occurrence of depressive symptoms with keratoconus. A different and interesting field for further research is the association of keratoconus with schizophrenia, as these diseases may have a common background. Conclusions: A review of the literature does not identify a 'keratoconus personality', but there are reports of specific functioning in patients with keratoconus. There are isolated reports in the literature regarding the co-occurrence of keratoconus and depressive-anxiety disorder. Keywords: depression, personality, anxiety, psychiatric disorders, keratoconus
{"title":"Mental disorders in people with keratoconus","authors":"Szymon Florek, R. Pudlo, P. Gościniewicz, Ewa Mrukwa-Kominek3","doi":"10.12923/2353-8627/2023-0003","DOIUrl":"https://doi.org/10.12923/2353-8627/2023-0003","url":null,"abstract":"Introduction: There are many reports on the association of various psychiatric disorders with visual impairment. The association of dry eye syndrome with depressive disorders has been particularly well documented. In the context of keratoconus patients group, data on similar relationships are inconclusive. Attempts have also been made to assess the personality of patients suffering from keratoconus, and the first study in this area was produced as early as 1976. Material and methods: For the literature review, full-text medical databases, such as PubMed and Embase, were searched for articles on the association of keratoconus with depressive-anxiety disorder and personality disorder. Articles published within the last 30 years were considered. Results: The personality of patients with keratoconus has been a research issue for many years, but research to date has not clearly defined what personality traits characterise this particular group of patients. Research into the relationship between keratoconus and depressive-anxiety disorders has only recently been conducted, and the results - although inconclusive - suggest a co-occurrence of depressive symptoms with keratoconus. A different and interesting field for further research is the association of keratoconus with schizophrenia, as these diseases may have a common background. Conclusions: A review of the literature does not identify a 'keratoconus personality', but there are reports of specific functioning in patients with keratoconus. There are isolated reports in the literature regarding the co-occurrence of keratoconus and depressive-anxiety disorder. Keywords: depression, personality, anxiety, psychiatric disorders, keratoconus","PeriodicalId":56342,"journal":{"name":"Current Problems of Psychiatry","volume":"116 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73024862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：